vs
Side-by-side financial comparison of RHYTHM PHARMACEUTICALS, INC. (RYTM) and Whitestone REIT (WSR). Click either name above to swap in a different company.
RHYTHM PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($60.1M vs $43.9M, roughly 1.4× Whitestone REIT). Whitestone REIT runs the higher net margin — 52.0% vs -92.6%, a 144.6% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (83.8% vs 7.5%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (43.8% CAGR vs 8.7%).
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
Whitestone REIT is a publicly traded real estate investment trust that acquires, owns, manages and redevelops open-air community shopping centers, primarily located in high-growth metropolitan areas across the southwestern and southeastern United States. Its property portfolio is largely anchored by daily necessity, service-focused retail tenants that cater to regular local consumer demand.
RYTM vs WSR — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $60.1M | $43.9M |
| Net Profit | $-55.6M | $22.8M |
| Gross Margin | 88.1% | — |
| Operating Margin | -87.1% | 53.0% |
| Net Margin | -92.6% | 52.0% |
| Revenue YoY | 83.8% | 7.5% |
| Net Profit YoY | — | 31.7% |
| EPS (diluted) | $-0.83 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $60.1M | — | ||
| Q4 25 | $57.3M | $43.9M | ||
| Q3 25 | $51.3M | $41.0M | ||
| Q2 25 | $48.5M | $37.9M | ||
| Q1 25 | $32.7M | $38.0M | ||
| Q4 24 | $41.8M | $40.8M | ||
| Q3 24 | $33.3M | $38.6M | ||
| Q2 24 | $29.1M | $37.6M |
| Q1 26 | $-55.6M | — | ||
| Q4 25 | $-47.5M | $22.8M | ||
| Q3 25 | $-52.9M | $18.3M | ||
| Q2 25 | $-46.6M | $5.1M | ||
| Q1 25 | $-49.5M | $3.7M | ||
| Q4 24 | $-43.3M | $17.3M | ||
| Q3 24 | $-43.6M | $7.6M | ||
| Q2 24 | $-32.3M | $2.6M |
| Q1 26 | 88.1% | — | ||
| Q4 25 | 91.6% | — | ||
| Q3 25 | 89.3% | — | ||
| Q2 25 | 88.6% | — | ||
| Q1 25 | 88.8% | — | ||
| Q4 24 | 90.9% | — | ||
| Q3 24 | 88.5% | — | ||
| Q2 24 | 89.9% | — |
| Q1 26 | -87.1% | — | ||
| Q4 25 | -82.2% | 53.0% | ||
| Q3 25 | -102.6% | 45.5% | ||
| Q2 25 | -93.4% | 13.8% | ||
| Q1 25 | -143.7% | 10.2% | ||
| Q4 24 | -98.6% | 43.3% | ||
| Q3 24 | -132.0% | 20.3% | ||
| Q2 24 | -139.2% | 7.2% |
| Q1 26 | -92.6% | — | ||
| Q4 25 | -83.0% | 52.0% | ||
| Q3 25 | -103.1% | 44.7% | ||
| Q2 25 | -96.1% | 13.3% | ||
| Q1 25 | -151.4% | 9.7% | ||
| Q4 24 | -103.6% | 42.5% | ||
| Q3 24 | -131.2% | 19.7% | ||
| Q2 24 | -110.9% | 6.9% |
| Q1 26 | $-0.83 | — | ||
| Q4 25 | $-0.73 | $0.43 | ||
| Q3 25 | $-0.82 | $0.35 | ||
| Q2 25 | $-0.75 | $0.10 | ||
| Q1 25 | $-0.81 | $0.07 | ||
| Q4 24 | $-0.71 | $0.34 | ||
| Q3 24 | $-0.73 | $0.15 | ||
| Q2 24 | $-0.55 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $340.6M | $4.9M |
| Total DebtLower is stronger | — | $649.4M |
| Stockholders' EquityBook value | $122.9M | $458.1M |
| Total Assets | $442.3M | $1.2B |
| Debt / EquityLower = less leverage | — | 1.42× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $340.6M | — | ||
| Q4 25 | $388.9M | $4.9M | ||
| Q3 25 | $416.1M | $6.8M | ||
| Q2 25 | $291.0M | $5.3M | ||
| Q1 25 | $314.5M | $5.6M | ||
| Q4 24 | $320.6M | $5.2M | ||
| Q3 24 | $298.4M | $2.5M | ||
| Q2 24 | $319.1M | $3.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | $649.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $632.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $122.9M | — | ||
| Q4 25 | $139.1M | $458.1M | ||
| Q3 25 | $148.8M | $439.5M | ||
| Q2 25 | $-11.9M | $427.5M | ||
| Q1 25 | $18.9M | $431.0M | ||
| Q4 24 | $21.7M | $438.2M | ||
| Q3 24 | $11.2M | $419.5M | ||
| Q2 24 | $39.3M | $418.3M |
| Q1 26 | $442.3M | — | ||
| Q4 25 | $480.2M | $1.2B | ||
| Q3 25 | $506.9M | $1.1B | ||
| Q2 25 | $372.7M | $1.2B | ||
| Q1 25 | $386.7M | $1.1B | ||
| Q4 24 | $392.3M | $1.1B | ||
| Q3 24 | $363.6M | $1.1B | ||
| Q2 24 | $381.8M | $1.1B |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.42× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.44× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $50.8M |
| Free Cash FlowOCF − Capex | — | $50.5M |
| FCF MarginFCF / Revenue | — | 114.9% |
| Capex IntensityCapex / Revenue | — | 0.7% |
| Cash ConversionOCF / Net Profit | — | 2.22× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-25.4M | $50.8M | ||
| Q3 25 | $-26.6M | $18.0M | ||
| Q2 25 | $-23.3M | $13.8M | ||
| Q1 25 | $-40.4M | $3.1M | ||
| Q4 24 | $-18.8M | $58.2M | ||
| Q3 24 | $-25.2M | $16.4M | ||
| Q2 24 | $-29.1M | $12.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | $50.5M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $58.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 114.9% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 142.1% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.7% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.22× | ||
| Q3 25 | — | 0.98× | ||
| Q2 25 | — | 2.74× | ||
| Q1 25 | — | 0.83× | ||
| Q4 24 | — | 3.36× | ||
| Q3 24 | — | 2.15× | ||
| Q2 24 | — | 4.73× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
